Morgan Stanley Initiates Coverage On Novartis With Equal-Weight Rating, Announces Price Target of $114
Morgan Stanley Initiates Coverage On Novartis With Equal-Weight Rating, Announces Price Target of $114
摩根士丹利以同等權重評級啓動對諾華的報道,宣佈目標股價爲114美元
Morgan Stanley analyst Mark Purcell initiates coverage on Novartis (NYSE:NVS) with a Equal-Weight rating and announces Price Target of $114.
摩根士丹利分析師馬克·珀塞爾以等權重評級開始對諾華(紐約證券交易所代碼:NVS)進行報道,並宣佈目標股價爲114美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。